Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5.

BMC Mol Biol

Wellcome Centre for Molecular Parasitology and Division of Infection & Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, UK.

Published: November 2006

AI Article Synopsis

  • The study focused on L. infantum JPCM5, a newly characterized laboratory model for visceral leishmaniasis, which retains virulence and allows for genetic manipulation.
  • Researchers created LiCPA-deficient clones (DeltaLicpa) and found a significant reduction in their virulence compared to other species, indicating the importance of the cysteine peptidase LiCPA.
  • The findings suggest that while LiCPA is not essential for the growth of L. infantum in vitro, it is crucial for effective interaction with host cells, highlighting the need for more research to understand its complex role in both in vitro and in vivo contexts.

Article Abstract

Background: Visceral leishmaniasis caused by members of the Leishmania donovani complex is often fatal in the absence of treatment. Research has been hampered by the lack of good laboratory models and tools for genetic manipulation. In this study, we have characterised a L. infantum line (JPCM5) that was isolated from a naturally infected dog and then cloned. We found that JPCM5 has attributes that make it an excellent laboratory model; different stages of the parasite life cycle can be studied in vitro, it is accessible to genetic manipulation and it has retained its virulence. Furthermore, the L. infantum JPCM5 genome has now been fully sequenced.

Results: We have further focused our studies on LiCPA, the L. infantum homologue to L. mexicana cysteine peptidase CPA. LiCPA was found to share a high percentage of amino acid identity with CPA proteins of other Leishmania species. Two independent LiCPA-deficient promastigote clones (DeltaLicpa) were generated and their phenotype characterised. In contrast to L. mexicana CPA-deficient mutants, both clones of DeltaLicpa were found to have significantly reduced virulence in vitro and in vivo. Re-expression of just one LiCPA allele (giving DeltaLicpa::CPA) was sufficient to complement the reduced infectivity of both DeltaLicpa mutants for human macrophages, which confirms the importance of LiCPA for L. infantum virulence. In contrast, in vivo experiments did not show any virulence recovery of the re-expressor clone DeltaLicpaC1::CPA compared with the CPA-deficient mutant DeltaLicpaC1.

Conclusion: The data suggest that CPA is not essential for replication of L. infantum promastigotes, but is important for the host-parasite interaction. Further studies will be necessary to elucidate the precise roles that LiCPA plays and why the re-expression of LiCPA in the DeltaLicpa mutants complemented the gene deletion phenotype only in in vitro and not in in vivo infection of hamsters.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1657026PMC
http://dx.doi.org/10.1186/1471-2199-7-42DOI Listing

Publication Analysis

Top Keywords

cysteine peptidase
8
genetic manipulation
8
infantum jpcm5
8
licpa infantum
8
clones deltalicpa
8
vitro vivo
8
re-expression licpa
8
deltalicpa mutants
8
infantum
6
licpa
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!